脏器官在ACE2-依赖的SARS-CoV-2感染期间显示病毒进入途径的冗余性
Jessica M Vanslambrouck1,2, Jessica A Neil3, Rajeev Rudraraju3
1The Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Murdoch Children's Research Institute, Melbourne, Australia.
Journal of virology
|February 9, 2024
概括
这项研究表明,SARS-CoV-2主要通过ACE2通过双重处理途径感染脏近道管细胞. 像利西诺普利尔这样的常见血压药物不会增加细胞对COVID-19感染的易感性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 病毒学 病毒学
- 细胞生物学 细胞生物学
背景情况:
- COVID-19 患者经常经历急性损伤,促使对 SARS-CoV-2 直接向脏的调查.
- 以前使用脏器官的研究表明,SARS-CoV-2感染了近道管细胞,但器官不成熟性限制了对病毒途径和药物效应的理解.
- 在细胞中SARS-CoV-2进入和处理的精确机制以及抗高血压药物的影响仍然不清楚.
研究的目的:
- 为了阐明SARS-CoV-2进入人类细胞的机制,使用一种新的,成熟的近接管体有机体模型.
- 确定SARS-CoV-2在结合细胞中的ACE2受体后利用的病毒处理途径.
- 评估ACE抑制剂利西诺普里尔对脏细胞易受SARS-CoV-2感染的影响.
主要方法:
- 开发和使用人类诱导多能干细胞 (iPSC) 衍生器官,增强近接管道 (PT) 成熟度.
- 采用基因和药物介导的抑制来研究病毒的进入和处理因素.
- 将SARS-CoV-2注射到有机体中,并用lisinopril治疗以评估感染易感性.
主要成果:
- 证实ACE2是SARS-CoV-2进入细胞的必要受体.
- 确定了双重的病毒处理途径:一个涉及TMPRSS10的非内体途径和一个涉及Cathepsins (CTSL/CTSB) 的内细胞途径.
- 证明利西诺普里尔治疗对ACE2表达或脏器官中的SARS-CoV-2感染率没有显著影响.
结论:
- 这项研究提供了SARS-CoV-2进入成熟人类器官的第一个详细表征.
- 这些发现澄清了ACE2和下游处理途径在脏SARS-CoV-2感染中的作用.
- 研究表明,Lisinopril等ACE抑制剂不会增加脏细胞对SARS-CoV-2的脆弱性.
相关概念视频
Viral Recombination
22.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
22.3K
Infection
11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K


